Sickle Cell Disease Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2020 – 2030

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

The US Sickle Cell Disease (SCD) market size was valued at $227.7 million in 2020 and is expected to achieve a CAGR of more than 33% during 2020-2030. Sickle cell disease (SCD) is a genetic, lifelong blood disorder that results in the formation of sickled red blood cells causing severe complications across multiple organ systems. It is inherited in an autosomal recessive pattern, where a single-nucleotide polymorphism in the β-globin gene causes glutamic acid to be replaced by valine, a hydrophobic amino acid. It is inherited when a child receives two SCD genes—one from each parent—and is most often diagnosed at birth with a simple blood test.

The SCD market research report will help you to drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies that are likely to impact the global SCD market in the future. The report will also help you to identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

US Sickle Cell Disease Market Overview, 2020 ($ Million)

SCD Market Size and Trend Report including Epidemiology

To gain more information on the SCD market forecast, download a free report sample

SCD Market Drivers

The launch of six new treatments is expected across the forecast period. This includes two first-in-class gene therapies (bb1111 and CTX001), which will drive a significant increase in the overall market size of SCD as more therapeutic options become available to patients.

SCD Market Segmentation by Type

The key types of the SCD market are HbSS, HbSC, HbSβ0 thal, and HbSβ+ thal. In 2020, the HbSS led the SCD market.

Sickle Cell Disease Market Analysis by Type, 2020 (%)

SCD Market Analysis by Type

For more insights into the segments, download a free report sample

Hand SCD Market Segmentation by Drug

The key drugs in the SCD market are Oxbryta (voxelotor), Droxia (hydroxyurea), Endari (L-glutamine), and Adakveo (crizanlizumab). In 2020, Oxbryta (voxelotor) had the largest market share.

Hand Sickle Cell Disease Market Analysis by Drug, 2020 (%)

Hand SCD Market Analysis by Drug

For more drug segment insights into the hand SCD market, download a free report sample

Competitive Landscape

Some of the leading players in the SCD market are Bluebird Bio/Pasteur Institute, Genmab/Roche And Global Blood Therapeutics, Forma Therapeutics, Agios Pharmaceuticals, H.Lundbeck/Imara, CRISPR/Vertex, Editas Medicine, Sangamo/Sanofi And Bioverativ, and Stanford/Graphite Bio.

SCD Market Report Overview

  Market Size (2020)  $227.7 million
  CAGR (2020 – 2030)  >33%
Forecast Period 2021-2030
 Key Type HbSS, HbSC, HbSβ0 thal, and HbSβ+ thal
Key Drug Oxbryta (voxelotor), Droxia (hydroxyurea), Endari (L-glutamine), and Adakveo (crizanlizumab)
 Leading Players Bluebird Bio/Pasteur Institute, Genmab/Roche And Global Blood Therapeutics, Forma Therapeutics, Agios Pharmaceuticals, H.Lundbeck/Imara, CRISPR/Vertex, Editas Medicine, Sangamo/Sanofi, and Bioverativ, and Stanford/Graphite Bio

SCD Market Types Outlook ( Value, $ Million, 2020-2030)

  • HbSS
  • HbSC
  • HbSβ0 thal
  • HbSβ+ thal

SCD Market Drugs Outlook ( Value, $ Million, 2020-2030)

  • Oxbryta (voxelotor)
  • Droxia (hydroxyurea)
  • Endari (L-glutamine)
  • Adakveo (crizanlizumab)

Scope

  • GlobalData’s SCD market size and trend report including epidemiology and pipeline analysis, competitor assessment, unmet needs, clinical trial strategies, and forecast, 2020 – 2030 combines data from the pharma intelligence center with in-house analyst expertise to provide a competitive assessment of the disease marketplace

Reasons to Buy

The report will enable you to:

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the global SCD market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global SCD market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Bristol Myers Squibb
Emmaus Life Sciences
Global Blood Therapeutics
Novartis Pharmaceuticals
bluebird bio
Genmab/Roche
Forma Therapeutics
Agios Pharmaceuticals
H.Lundbeck/Imara
CRISPR/Vertex
Editas Medicine
Graphite Bio
Sangamo/Sanofi
Bioverativ

Table of Contents

1 Executive Summary

2 Disease Overview

2 Disease Overview

3 Epidemiology

4 Current Treatment Options

5 Unmet Needs and Opportunities

6 Pipeline Assessment

7 R&D Strategies

8 Market Outlook

9 Appendix

10 Contact Us

Table

Table 1. Marketed Products

Table 2. Leading Pipeline Agents

Table 3. Pipeline Products: FDA Review Designations

Figures

Figure 1: Summary of Key Findings

Figure 2. Treatment Paradigm

Figure 3. Unmet Needs

Figure 4. Pipeline Overview

Figure 5. Clinical Trials Overview

Figure 6. Market Forecast

Frequently asked questions

Sickle Cell Disease Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2020 – 2030 standard reports
Currency USD
$6,995

Can be used by individual purchaser only

$20,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Sickle Cell Disease Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2020 – 2030 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Sickle Cell Disease Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2020 – 2030 in real time.

  • Access a live Sickle Cell Disease Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2020 – 2030 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.